OA10993A - Compostions pharmaceutiques pour le traitement de maladies virales - Google Patents
Compostions pharmaceutiques pour le traitement de maladies virales Download PDFInfo
- Publication number
- OA10993A OA10993A OA9900054A OA9900054A OA10993A OA 10993 A OA10993 A OA 10993A OA 9900054 A OA9900054 A OA 9900054A OA 9900054 A OA9900054 A OA 9900054A OA 10993 A OA10993 A OA 10993A
- Authority
- OA
- OAPI
- Prior art keywords
- pharmaceutical composition
- vsr
- use according
- pharmaceutically acceptable
- active ingredient
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96870114 | 1996-09-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA10993A true OA10993A (fr) | 2003-03-04 |
Family
ID=8226163
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA9900054A OA10993A (fr) | 1996-09-11 | 1999-03-10 | Compostions pharmaceutiques pour le traitement de maladies virales |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6413970B1 (no) |
| EP (1) | EP0936909A1 (no) |
| JP (1) | JP2001500143A (no) |
| KR (1) | KR20000036025A (no) |
| CN (1) | CN1230116A (no) |
| AP (1) | AP9901474A0 (no) |
| AR (1) | AR009756A1 (no) |
| AU (1) | AU717354B2 (no) |
| BR (1) | BR9712033A (no) |
| CA (1) | CA2265542A1 (no) |
| CZ (1) | CZ83099A3 (no) |
| EA (1) | EA001262B1 (no) |
| HU (1) | HUP9904173A3 (no) |
| ID (1) | ID21369A (no) |
| IL (1) | IL128351A0 (no) |
| NO (1) | NO991164D0 (no) |
| NZ (1) | NZ334571A (no) |
| OA (1) | OA10993A (no) |
| PE (1) | PE107598A1 (no) |
| PL (1) | PL332316A1 (no) |
| TR (1) | TR199900523T2 (no) |
| WO (1) | WO1998010764A1 (no) |
| ZA (1) | ZA977874B (no) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2324242A (en) * | 1997-04-18 | 1998-10-21 | Atindra Nath Chakrabarty | Medicaments for treating viral infections |
| NZ515418A (en) | 1999-06-28 | 2003-11-28 | Janssen Pharmaceutica Nv | Respiratory syncytial virus replication inhibitors |
| EA004746B1 (ru) | 1999-06-28 | 2004-08-26 | Янссен Фармацевтика Н.В. | Производные бензимидазола и имидазопиридина в качестве ингибиторов репликации респираторно-синцитиального вируса |
| EP1196409B1 (en) | 1999-06-28 | 2004-02-04 | Janssen Pharmaceutica N.V. | Respiratory syncytial virus replication inhibitors |
| ATE386526T1 (de) * | 2002-07-02 | 2008-03-15 | Ucb Farchim Sa | Diarylmethylpiperazines als prophylaktische oder therapeutische mittel gegen virale myocarditis |
| US20040186112A1 (en) * | 2002-12-04 | 2004-09-23 | Dr. Reddy's Laboratories Limited | Polymorphic forms of dihydrochloride salts of cetirizine and processes for preparation thereof |
| KR100698400B1 (ko) | 2004-04-14 | 2007-03-23 | 이은주 | 탈모증 및 전립선비대증 치료를 위한 약제학적 조성물 |
| CN102988346A (zh) * | 2012-11-19 | 2013-03-27 | 何晓涛 | Aphanamixoid A在抗呼吸道合胞病毒的药物中的应用 |
| CN103356650A (zh) * | 2013-07-04 | 2013-10-23 | 丁圣雨 | Chukrasone A在抗呼吸道合胞病毒的药物中的应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI75816C (fi) * | 1981-02-06 | 1988-08-08 | Ucb Sa | Foerfarande foer framstaellning av terapeutiskt aktiv 2-/4-(difenylmetyl)-1-piperazinyl/-aettiksyror eller dess amid. |
-
1997
- 1997-08-26 PE PE1997000761A patent/PE107598A1/es not_active Application Discontinuation
- 1997-09-02 ZA ZA977874A patent/ZA977874B/xx unknown
- 1997-09-08 CZ CZ99830A patent/CZ83099A3/cs unknown
- 1997-09-08 HU HU9904173A patent/HUP9904173A3/hu unknown
- 1997-09-08 JP JP10513226A patent/JP2001500143A/ja active Pending
- 1997-09-08 KR KR1019997002003A patent/KR20000036025A/ko not_active Application Discontinuation
- 1997-09-08 EA EA199900226A patent/EA001262B1/ru not_active IP Right Cessation
- 1997-09-08 NZ NZ334571A patent/NZ334571A/xx unknown
- 1997-09-08 PL PL97332316A patent/PL332316A1/xx unknown
- 1997-09-08 CN CN97197831A patent/CN1230116A/zh active Pending
- 1997-09-08 AP APAP/P/1999/001474A patent/AP9901474A0/en unknown
- 1997-09-08 IL IL12835197A patent/IL128351A0/xx unknown
- 1997-09-08 WO PCT/EP1997/004859 patent/WO1998010764A1/en not_active Application Discontinuation
- 1997-09-08 US US09/254,548 patent/US6413970B1/en not_active Expired - Fee Related
- 1997-09-08 CA CA002265542A patent/CA2265542A1/en not_active Abandoned
- 1997-09-08 EP EP97944846A patent/EP0936909A1/en not_active Withdrawn
- 1997-09-08 BR BR9712033-2A patent/BR9712033A/pt not_active Application Discontinuation
- 1997-09-08 TR TR1999/00523T patent/TR199900523T2/xx unknown
- 1997-09-08 ID IDW990073A patent/ID21369A/id unknown
- 1997-09-08 AU AU46213/97A patent/AU717354B2/en not_active Ceased
- 1997-09-11 AR ARP970104166A patent/AR009756A1/es not_active Application Discontinuation
-
1999
- 1999-03-10 OA OA9900054A patent/OA10993A/fr unknown
- 1999-03-10 NO NO991164A patent/NO991164D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2265542A1 (en) | 1998-03-19 |
| BR9712033A (pt) | 2000-01-18 |
| JP2001500143A (ja) | 2001-01-09 |
| ZA977874B (en) | 1999-03-02 |
| EP0936909A1 (en) | 1999-08-25 |
| HUP9904173A2 (hu) | 2000-05-28 |
| ID21369A (id) | 1999-05-27 |
| EA001262B1 (ru) | 2000-12-25 |
| CZ83099A3 (cs) | 1999-06-16 |
| NZ334571A (en) | 2000-10-27 |
| AP9901474A0 (en) | 1999-03-31 |
| IL128351A0 (en) | 2000-01-31 |
| AU4621397A (en) | 1998-04-02 |
| CN1230116A (zh) | 1999-09-29 |
| WO1998010764A1 (en) | 1998-03-19 |
| AU717354B2 (en) | 2000-03-23 |
| TR199900523T2 (xx) | 1999-05-21 |
| PE107598A1 (es) | 1999-01-29 |
| HUP9904173A3 (en) | 2001-04-28 |
| AR009756A1 (es) | 2000-05-03 |
| NO991164L (no) | 1999-03-10 |
| US6413970B1 (en) | 2002-07-02 |
| PL332316A1 (en) | 1999-08-30 |
| NO991164D0 (no) | 1999-03-10 |
| KR20000036025A (ko) | 2000-06-26 |
| EA199900226A1 (ru) | 1999-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11344545B2 (en) | Use of levocetirizine and montelukast in the treatment of autoimmune disorders | |
| US20220218670A1 (en) | Methods of treating diseases characterised by vasoconstriction | |
| US10772886B2 (en) | CXCR-2 inhibitors for treating crystal arthropathy disorders | |
| Budde et al. | A phase I study of pulse high‐dose vorinostat (V) plus rituximab (R), ifosphamide, carboplatin, and etoposide (ICE) in patients with relapsed lymphoma | |
| WO2006092741A2 (en) | Treatment of inflammatory disorders with praziquantel | |
| OA10993A (fr) | Compostions pharmaceutiques pour le traitement de maladies virales | |
| JP2011515469A (ja) | シクロプロピル−ｎ−｛２−［（１ｓ）−１−（３−エトキシ−４−メトキシフェニル）−２−（メチルスルホニル）エチル］−３−オキソイソインドリン−４−イル｝カルボキサミドを使用した乾癬又は乾癬性関節炎の治療 | |
| JP2022511380A (ja) | 血清尿酸を低減させるための組成物 | |
| Hay et al. | Treatment of chronic mucocutaneous candidosis with ketoconazole: a study of 12 cases | |
| KR20230048517A (ko) | 베타 코로나바이러스 감염과 연관된 질환을 치료 또는 예방하기 위한 조성물 및 방법 | |
| CN102858329B (zh) | 用于治疗疾病的化合物 | |
| JP2002516283A (ja) | 核転写因子ＮＦ−κＢの活性化の阻害剤としての２−ヒドロキシ−４−トリフルオロメチル安息香酸誘導体の使用 | |
| JP2009078977A (ja) | 心筋の小胞体ストレス抑制剤 | |
| US20220072031A1 (en) | Treatment of viral infection | |
| CN114288288B (zh) | 一种gsdmd抑制剂及在制备神经免疫疾病、炎症感染疾病防治药物中的应用 | |
| MX2014012376A (es) | Metodo para tratar hiperucemia en pacientes con gota usando halofenato o acido halofenico y un agente anti - inflamatorio. | |
| WO2024036578A1 (en) | Methods for preventing or treating h. pylori infection | |
| Vassileva et al. | Drug repurposing of dermatologic medications to treat coronavirus disease 2019: Science or fiction? | |
| EP1389120B1 (fr) | Utilisation de la nystatine pour le traitement de l'athérosclérose liée à la présence de champignons parasites | |
| CN112843065B (zh) | 一种用于认知障碍的药物及其制备方法 | |
| JP7271474B2 (ja) | 炎症性サイトカインレベル阻害剤およびサイトカイン放出症候群の治療薬物を製造するに用いられる医薬組成物の用途 | |
| EA034885B1 (ru) | Новая схема лечения тиакумициновым соединением | |
| FR2910811A1 (fr) | Utilisation du riluzole et de ses derives pour fabriquer de nouveaux medicaments | |
| MXPA99002240A (en) | Pharmaceutical composition for treating viral diseases | |
| WO2021203001A1 (en) | Method of treating patients infected with a viral infection with an inhibitor of small ubiquitin like modifier activating enzyme |